PHAT Phathom Pharmaceuticals
- 6.960
- 0.0000.00%
- 7.200
- +0.240+3.45%
Phathom Pharmaceuticals所有资讯
Phathom Pharmaceuticals | 4：持股变动声明-高管 Nabulsi Azmi
Phathom Pharmaceuticals | 4：持股变动声明-高管 Henderson Molly
Phathom Pharmaceuticals | 4：持股变动声明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4：持股变动声明-董事 Parikh Asit
Phathom Pharmaceuticals | 8-K：重大事件
Phathom Pharmaceuticals | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | 10-Q：2024财年三季报
Phathom Pharmaceuticals | 8-K：Phathom Pharmicals公布2024年第三季度财务业绩并提供业务最新情况
Phathom Pharmaceuticals | SCHEDULE 13G/A：其他
Phathom Pharmaceuticals | SCHEDULE 13G：其他
Phathom Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Jennison Associates LLC(10.4%)
Phathom Pharmaceuticals | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | SC 13D/A：超过5%持股股东披露文件(修正)-James N. Topper(18.0%),Patrick J. Heron(18.0%)等
Phathom Pharmaceuticals | 8-K：重大事件
Phathom Pharmaceuticals | 424B5：募资说明书
Phathom Pharmaceuticals | FWP：自由书写募资说明书
Phathom Pharmaceuticals | 10-Q：2024财年二季报
Phathom Pharmaceuticals | 8-K：Phathom Pharmicals公布2024年第二季度财务业绩并提供业务最新情况
Phathom Pharmaceuticals | 8-K：重大事件
Phathom Pharmaceuticals | 4：持股变动声明-高管 Nabulsi Azmi
暂无数据